Cue Biopharma Inc. (NASDAQ: CUE) Stock Information | RedChip

Cue Biopharma Inc. (NASDAQ: CUE) Listen to this Section


$0.67
+0.0741 ( +12.48% ) 192.4K

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

Market Data


Open


$0.67

Previous close


$0.59

Volume


192.4K

Market cap


$33.03M

Day range


$0.59 - $0.68

52 week range


$0.58 - $3.25

Insider Ownership Transactions

Total Amount Purchased: -140,000.00 | $ -93,520.00

Date Type Amount Purchased Purchaser
2024-02-22 Sale -25000.00 Levisetti Matteo
2024-01-04 Sale -24400.00 Morich Frank
2024-01-04 Sale -24400.00 Garzone Pamela
2024-01-04 Sale -24400.00 Kiener Peter A
2024-01-04 Sale -24400.00 DRISCOLL FREDERICK W
2024-01-04 Sale -24400.00 Verheyen Patrick
2023-08-29 Buy 4000.00 Suri Anish
2023-08-16 Buy 3000.00 PASSERI DANIEL R

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 72 May 09, 2024
def Proxies and info statements 8 Apr 26, 2024
ars Annual reports 1 Apr 26, 2024
10-k Annual reports 103 Mar 28, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Feb 22, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.